SGMT · CIK 0001400118 · FY2025 live · 2025-12-31
Sagimet Biosciences Inc.
View as
Model
Classic Z
FY2025
8.47
Zone
Safe
Prior
—
Market DD
—
1y PD
—
Meridian Rank
71.09
0–100 · Classic Z tape · not a PD
Book standing
97
Year change
—
Market PD
—
O-score
2
Events on this name
Same published rows as Today. Not a live recompute.
APPROACHING GREY
watch · 41
- liveZ: — → 8.473249885965354
- cut: — → 1.8
8.47
Z″ 16.22
Score 8.47 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.961.2 × = 1.15X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−2.971.4 × = −4.16X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.493.3 × = −1.61X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
21.840.6 × = 13.10X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Sagimet Biosciences Inc. is on classic Z at 8.47 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Safe; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 96th percentile in Healthcare.
- SIONSafeSionna Therapeutics, Inc.8.47
- UTHRSafeUNITED THERAPEUTICS Corp8.46
- INMDSafeInMode Ltd.8.53
- TRVISafeTrevi Therapeutics, Inc.8.68
- APUSSafeApimeds Pharmaceuticals US, Inc.8.19
- MHUAFSafeMeihua International Medical Technologies Co., Ltd.8.18
- GRCESafeGrace Therapeutics, Inc.8.83
- IMRXSafeImmuneering Corp8.03
KPI widgets
Current assets
$116M
Total assets
$116M
Current liabilities
$5M
Total liabilities
$5M
Working capital
$111M
Retained earnings
−$346M
EBIT
−$57M
Total sales
$0
Book equity
$111M
Accession 0001104659-26-026140. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.